Denmark stocks were lower after the close on Thursday, as losses in the Real Estate, Personal & Household Goods and ...

In this article, we will discuss the 12 High Growth Large Cap Stocks to Buy Now. BlackRock highlighted that its portfolio ...

Assetmark Inc. boosted its stake in shares of Genmab A/S (NASDAQ:GMAB – Free Report) by 16.2% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 82,629 shares of ...

Deutsche Bank lowered the firm’s price target on Genmab (GMAB) to DKK 2,250 from DKK 2,500 and keeps a Buy rating on the shares.

Harding Loevner International Equity ADR composite rose 9.2%, gross, in Q3 2024, outpacing the 8.2% gain of the MSCI All ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good afternoon. Thank you for attending the Babcock & Wilcox ...

The S&P 500 index moved -0.0%. GMAB's trading volume is 291,380 compared to the stock's average volume of 894,412. Genmab A/S ...

GEN1047, GEN3017, and GEN1056—to refocus resources, following its recent $1.8 billion acquisition of ProfoundBio. The move ...

An influx of late-phase programs has prompted Genmab to reassess its bets. | An influx of late-phase programs has prompted Genmab to reassess its bets. The biotech is axing three early-stage clinical ...

In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Genmab (GMAB – Research Report). The company’s shares closed yesterday at $22.33. Goonewardene covers ...

Genmab AS (GMAB) reports a 29% revenue increase and strategic moves in its product pipeline, despite challenges in ...

Genmab reported impressive earnings with significant revenue growth driven by its key products, despite rising expenses.